Literature DB >> 17442906

Targeted therapy for inherited GPI deficiency.

Antonio M Almeida1, Yoshiko Murakami, Alastair Baker, Yusuke Maeda, Irene A G Roberts, Taroh Kinoshita, D Mark Layton, Anastasios Karadimitris.   

Abstract

Disrupted binding of the transcription factor Sp1 to the mutated promoter region of the mannosyl transferase-encoding gene PIGM causes inherited glycosylphosphatidylinositol (GPI) deficiency characterized by splanchnic vein thrombosis and epilepsy. We show that this results in histone hypoacetylation at the promoter of PIGM. The histone deacetylase inhibitor butyrate increases PIGM transcription and surface GPI expression in vitro as well as in vivo through enhanced histone acetylation in an Sp1-dependent manner. More important, the drug caused complete cessation of intractable seizures in a child with inherited GPI deficiency. Copyright 2007 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442906     DOI: 10.1056/NEJMoa063369

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  33 in total

1.  Neurology of inherited glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Lancet Neurol       Date:  2012-05       Impact factor: 44.182

2.  Tackling the epigenome: challenges and opportunities for collaboration.

Authors:  John S Satterlee; Dirk Schübeler; Huck-Hui Ng
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

Review 3.  Congenital disorders of glycosylation.

Authors:  Irene J Chang; Miao He; Christina T Lam
Journal:  Ann Transl Med       Date:  2018-12

4.  Identification and In Silico Characterization of a Novel Point Mutation within the Phosphatidylinositol Glycan Anchor Biosynthesis Class G Gene in an Iranian Family with Intellectual Disability.

Authors:  Negin Parsamanesh; Hossein Safarpour; Shokoofe Etesam; Aazam Ahmadi Shadmehri; Ebrahim Miri-Moghaddam
Journal:  J Mol Neurosci       Date:  2019-08-14       Impact factor: 3.444

Review 5.  Glycosylphosphatidylinositol-anchored proteins mediate the interactions between pollen/pollen tube and pistil tissues.

Authors:  Cai Yu Yu; Huan Kai Zhang; Ning Wang; Xin-Qi Gao
Journal:  Planta       Date:  2021-01-04       Impact factor: 4.116

6.  Generation of glycosylphosphatidylinositol anchor protein-deficient blood cells from human induced pluripotent stem cells.

Authors:  Xuan Yuan; Evan M Braunstein; Zhaohui Ye; Cyndi F Liu; Guibin Chen; Jizhong Zou; Linzhao Cheng; Robert A Brodsky
Journal:  Stem Cells Transl Med       Date:  2013-10-10       Impact factor: 6.940

Review 7.  Solving glycosylation disorders: fundamental approaches reveal complicated pathways.

Authors:  Hudson H Freeze; Jessica X Chong; Michael J Bamshad; Bobby G Ng
Journal:  Am J Hum Genet       Date:  2014-02-06       Impact factor: 11.025

Review 8.  Gene regulation and genetics in neurochemistry, past to future.

Authors:  Steven W Barger
Journal:  J Neurochem       Date:  2016-10-17       Impact factor: 5.372

Review 9.  Understanding human glycosylation disorders: biochemistry leads the charge.

Authors:  Hudson H Freeze
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

10.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.